P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPANSION BELLWAVE-001 STUDY
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 578-579
10.1097/01.hs9.0000845612.25766.0c